189 filings
Page 10 of 10
6-K
eoyfp 0i7
24 Oct 17
U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome
12:00am
6-K
6tzr2s24apq 94
12 Oct 17
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
12:00am
6-K
pc7 ne2a6
22 Sep 17
Current report (foreign)
12:00am
6-K
syz otrtnx
1 Sep 17
Current report (foreign)
12:00am
6-K
jdq2 kxjsqlk
25 Aug 17
Current report (foreign)
12:00am
6-K
gtqol07sqv0xaco65f
24 Aug 17
Interim report for the first half of 2017
12:00am
6-K
qwrkiknik
22 Aug 17
Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
12:00am
6-K
hlpc82o
18 Aug 17
Current report (foreign)
12:00am
6-K
kgyskk
14 Aug 17
Current report (foreign)
12:00am